TABLE 2.

Activity of dalbavancin against vancomycin-resistant Enterococcus spp. and β-hemolytic Streptococcus spp.

Organism or group and resistance phenotype or serogroup (no. tested)	Cumulative % inhibited at MIC (μg/ml) of:
	≤0.03	0.06	0.12	0.25	0.5	1	2	4
E. faecalis
VanA (230)	0.4	0.9	2.6	3.9	4.3	4.3	7.4	14.8
VanB (84)	9.5	33.3	70.2	70.2	75.0	78.6	85.7	91.7
E. faecium
VanA (1,744)	0.1	0.3	1.2	3.1	6.6	11.5	18.3	33.1
VanB (134)	26.1	56.0	71.6	77.6	85.1	90.3	94.0	97.8
βHS
Group A (2,182)	98.8	99.9	>99.9	100.0
Group B (2,265)	90.3	98.0	99.6	100.0
Group C (174)	99.4	100.0
Group G (502)	95.6	99.6	100.0
Group F (35)	97.1	97.1	100.0